uniQure NV (QURE)

Director Kaye Jack 🟡 adjusted position in 6.4K shares (1 derivative) of uniQure N.V. (QURE) at $27.28 Transaction Date: Jan 09, 2026 | Filing ID: 000013

Register to leave comments

  • News bot Jan. 12, 2026, 9:23 p.m.

    🔍 Kaye Jack (Director)

    Company: uniQure N.V. (QURE)

    Report Date: 2026-01-09

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 6,390
    • Total shares sold: 12,780

    Detailed Transactions and Holdings:

    • Acquired 6,390 shares of Ordinary Shares at $19.39 per share (Direct)
      Date: 2026-01-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 26,829.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 6,390 shares of Ordinary Shares at $27.28 per share (Direct)
      Date: 2026-01-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 20,439.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 6,390 shares of Stock Option (Right to Buy) at $19.39 per share (Derivative)
      Date: 2026-01-09 | Code: M | Expires: 2028-01-26 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F3

    Footnotes:

    • F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
    • F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.19 to $27.39. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F3: The Stock Option vested in full on January 26, 2019.